🇰🇷 Vantas in South Korea

Vantas (HISTRELIN) regulatory status in South Korea.

Marketing authorisations

MFDS

  • Status: likely_approved

MFDS

  • Status: likely_approved

Vantas in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in South Korea

Frequently asked questions

Is Vantas approved in South Korea?

Yes. MFDS has authorised it; MFDS has authorised it.

Who is the marketing authorisation holder for Vantas in South Korea?

Marketing authorisation holder not available in our data.